Catherine R. Weiler

1.7k total citations
51 papers, 813 citations indexed

About

Catherine R. Weiler is a scholar working on Immunology, Rheumatology and Surgery. According to data from OpenAlex, Catherine R. Weiler has authored 51 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 23 papers in Rheumatology and 16 papers in Surgery. Recurrent topics in Catherine R. Weiler's work include Mast cells and histamine (18 papers), Eosinophilic Disorders and Syndromes (15 papers) and Eosinophilic Esophagitis (13 papers). Catherine R. Weiler is often cited by papers focused on Mast cells and histamine (18 papers), Eosinophilic Disorders and Syndromes (15 papers) and Eosinophilic Esophagitis (13 papers). Catherine R. Weiler collaborates with scholars based in United States, Singapore and Italy. Catherine R. Weiler's co-authors include Joseph H. Butterfield, Anupama Ravi, Farrah J. Mateen, Hirohito Kita, Jay C. Erie, Gerald J. Gleich, Richard G. Van Dellen, Paul A. Decker, Megan M. O’Byrne and Margaret J. Hukee and has published in prestigious journals such as The Journal of Immunology, Journal of Allergy and Clinical Immunology and The American Journal of Gastroenterology.

In The Last Decade

Catherine R. Weiler

51 papers receiving 778 citations

Peers

Countries citing papers authored by Catherine R. Weiler

Since Specialization

Citations

This map shows the geographic impact of Catherine R. Weiler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine R. Weiler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine R. Weiler more than expected).

Fields of papers citing papers by Catherine R. Weiler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine R. Weiler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine R. Weiler. The network helps show where Catherine R. Weiler may publish in the future.

Co-authorship network of co-authors of Catherine R. Weiler

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine R. Weiler. A scholar is included among the top collaborators of Catherine R. Weiler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine R. Weiler. Catherine R. Weiler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation Syndrome 2020 ·The Journal of Allergy and Clinical Immunology In Practice ·Joseph H. Butterfield, Catherine R. Weiler	28
2	Mast Cell Activation Syndrome: Tools for Diagnosis and Differential Diagnosis 2019 ·The Journal of Allergy and Clinical Immunology In Practice ·Catherine R. Weiler	23
3	AAAAI Mast Cell Disorders Committee Work Group Report: Mast cell activation syndrome (MCAS) diagnosis and management 2019 ·Journal of Allergy and Clinical Immunology ·Catherine R. Weiler, K. Frank Austen, Cem Akin, (unknown), Jonathan A. Bernstein, Patrizia Bonadonna, Joseph H. Butterfield, Melody Carter, Charity C. Fox, Anne Maitland, Thanai Pongdee, S. Shahzad Mustafa, Anupama Ravi, Mary C. Tobin, Harissios Vliagoftis, Lawrence B. Schwartz	68
4	Mast Cell Activation Syndrome: Improved Identification by Combined Determinations of Serum Tryptase and 24-Hour Urine 11β-Prostaglandin2α 2014 ·The Journal of Allergy and Clinical Immunology In Practice ·Anupama Ravi, Joseph H. Butterfield, Catherine R. Weiler	46
5	Treatment of Hypereosinophilic Syndromes—The First 100 Years 2012 ·Seminars in Hematology ·Joseph H. Butterfield, Catherine R. Weiler	16
6	Treatment‐refractory idiopathic hypereosinophilic syndrome: Pitfalls and progress with use of novel drugs 2012 ·American Journal of Hematology ·Jonathan Bleeker, (unknown), Leslie T. Cooper, Catherine R. Weiler, Ayalew Tefferi, Animesh Pardanani	5
7	The Melkersson–Rosenthal syndrome: a retrospective study of biopsied cases 2012 ·Journal of Neurology ·(unknown), Farrah J. Mateen, Catherine R. Weiler	49
8	Eosinophilic Esophagitis: Allergic Contribution, Testing, and Management 2012 ·Current Gastroenterology Reports ·(unknown), Catherine R. Weiler, David A. Katzka	10
9	Eosinophilic Gastrointestinal Disorders (EGID) with Peripheral Eosinophilia: A Retrospective Review at Mayo Clinic 2011 ·Digestive Diseases and Sciences ·Joo-Hee Lee, Ross Dierkhising, Tsung‐Teh Wu, Jeffrey A. Alexander, Catherine R. Weiler	13
10	Use of pegylated interferon in hypereosinophilic syndrome 2011 ·Leukemia Research ·Joseph H. Butterfield, Catherine R. Weiler	15
11	Prevention of Mast Cell Activation Disorder-Associated Clinical Sequelae of Excessive Prostaglandin D<sub>2</sub> Production 2008 ·International Archives of Allergy and Immunology ·Joseph H. Butterfield, Catherine R. Weiler	60
12	Preclinical rituximab treatment in Sjogren's syndrome: Histological evidence of major glandular restoration 2007 ·Data Archiving and Networked Services (DANS) ·Stephan Ihrler, Catherine R. Weiler, Andrea Sendelhofert, Oliver Reichel, Justin Pijpe	1
13	Monoclonal gammopathies and malignancies in patients with chronic urticaria 2006 ·International Journal of Dermatology ·(unknown), (unknown), Gerald W. Volcheck, Catherine R. Weiler	14
14	Genetic Test Indications and Interpretations in Patients With Hereditary Angioedema 2006 ·Mayo Clinic Proceedings ·Catherine R. Weiler, Richard G. Van Dellen	23
15	Common Variable Immunodeficiency: Test Indications and Interpretations 2005 ·Mayo Clinic Proceedings ·Catherine R. Weiler, Jennifer L. Bankers‐Fulbright	16
16	Cockroach Allergen-Induced Eosinophilic Airway Inflammation in HLA-DQ/Human CD4+ Transgenic Mice 2001 ·The Journal of Immunology ·Bettina G. Papouchado, Svetlana P. Chapoval, Eric Marietta, Catherine R. Weiler, Chella S. David	15
17	Peptide-based analysis of amino acid sequences important to the biological activity of eosinophil granule major basic protein 2001 ·Immunology Letters ·Larry L. Thomas, (unknown), (unknown), (unknown), Arthur J. Weaver, Daniel McCormick, Catherine R. Weiler, Gerald J. Gleich	13
18	Autoimmune Hemolytic Anemia in a Patient With Autosomal Dominant Chronic Mucocutaneous Candidiasis 2000 ·Mayo Clinic Proceedings ·David P. Steensma, Ayalew Tefferi, Catherine R. Weiler	6
19	Discordant and anomalous results among cytotoxicity assays: the confounding properties of eosinophil granule major basic protein on cell viability assays 1999 ·Journal of Immunological Methods ·(unknown), David A. Loegering, Yuji Tohda, Jennifer L. Bankers‐Fulbright, Catherine R. Weiler, (unknown), Larry L. Thomas, Cheryl R. Adolphson, Gerald J. Gleich	8
20	The use of neuromuscular blocking drugs in the intensive care unit: A US perspective 1993 ·Intensive Care Medicine ·Michael J. Murray, (unknown), Catherine R. Weiler	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact